Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2Phase 4 1Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 42Rectal Neoplasms 31Colorectal Neoplasms 31Pancreatic Neoplasms 30Neoplasms 26Stomach Neoplasms 20Neoplasm Metastasis 17Colonic Neoplasms 13Unspecified Adult Solid Tumor, Protocol Specific 12Esophageal Neoplasms 12Carcinoma, Non-Small-Cell Lung 11Solid Tumor 7Biliary Tract Neoplasms 7Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Liver Neoplasms 4Carcinoma, Hepatocellular 4Bile Duct Neoplasms 4Triple Negative Breast Neoplasms 3Prostatic Neoplasms 3Melanoma 3Head and Neck Neoplasms 3Gallbladder Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3Appendiceal Neoplasms 3Anus Neoplasms 3Adenocarcinoma 3Vaginal Neoplasms 2Uterine Cervical Neoplasms 2

Interventions

Cyclophosphamide 41fludarabine 31Dexamethasone 27venetoclax 24Cytarabine 22Rituximab 16pembrolizumab 15fludarabine phosphate 14Filgrastim 12Etoposide 12Lenalidomide 11Vincristine 10Gemcitabine 10Azacitidine 10pomalidomide 9Interleukin-2 9Granulocyte Colony-Stimulating Factor 9Doxorubicin 9Calcium Dobesilate 9carfilzomib 8Topotecan 8Nivolumab 8Methotrexate 8Everolimus 8Decitabine 8Bortezomib 8Melphalan 7Cisplatin 7Vorinostat 6Injections 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Recurrence × Capecitabine × Clear all
NCT02669173 2026-02-23

Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma

Case Comprehensive Cancer Center

Phase 1 Completed
12 enrolled
CNS

Brain Neoplasms, Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡